138 related articles for article (PubMed ID: 35660638)
1. Neuropeptide Y promotes hepatic apolipoprotein A1 synthesis and secretion through neuropeptide Y Y5 receptor.
Liu B; Chen F
Peptides; 2022 Aug; 154():170824. PubMed ID: 35660638
[TBL] [Abstract][Full Text] [Related]
2. NPY stimulates cholesterol synthesis acutely by activating the SREBP2-HMGCR pathway through the Y1 and Y5 receptors in murine hepatocytes.
Chen F; Zhou Y; Yang K; Shen M; Wang Y
Life Sci; 2020 Dec; 262():118478. PubMed ID: 32976883
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y regulates proliferation and apoptosis in granulosa cells in a follicular stage-dependent manner.
Urata Y; Salehi R; Lima PDA; Osuga Y; Tsang BK
J Ovarian Res; 2020 Jan; 13(1):5. PubMed ID: 31915051
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide y and neuropeptide y y5 receptor interaction restores impaired growth potential of aging bone marrow stromal cells.
Igura K; Haider HKh; Ahmed RP; Sheriff S; Ashraf M
Rejuvenation Res; 2011 Aug; 14(4):393-403. PubMed ID: 21595512
[TBL] [Abstract][Full Text] [Related]
5. Expression of hypoxia inducible factor-dependent neuropeptide Y receptors Y1 and Y5 sensitizes hypoxic cells to NPY stimulation.
Medeiros PJ; Pascetta SA; Kirsh SM; Al-Khazraji BK; Uniacke J
J Biol Chem; 2022 Mar; 298(3):101645. PubMed ID: 35093384
[TBL] [Abstract][Full Text] [Related]
6. Central nervous system neuropeptide Y signaling via the Y1 receptor partially dissociates feeding behavior from lipoprotein metabolism in lean rats.
Rojas JM; Stafford JM; Saadat S; Printz RL; Beck-Sickinger AG; Niswender KD
Am J Physiol Endocrinol Metab; 2012 Dec; 303(12):E1479-88. PubMed ID: 23074243
[TBL] [Abstract][Full Text] [Related]
7. Ethanol-mediated upregulation of APOA1 gene expression in HepG2 cells is independent of de novo lipid biosynthesis.
Khodja Y; Samuels ME
Lipids Health Dis; 2020 Jun; 19(1):144. PubMed ID: 32563265
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y Stimulates Proliferation and Migration of Vascular Smooth Muscle Cells from Pregnancy Hypertensive Rats via Y1 and Y5 Receptors.
Zhang P; Qi YX; Yao QP; Chen XH; Wang GL; Shen BR; Han Y; Gao LZ; Jiang ZL
PLoS One; 2015; 10(7):e0131124. PubMed ID: 26131716
[TBL] [Abstract][Full Text] [Related]
9. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
[TBL] [Abstract][Full Text] [Related]
10. Expression of neuropeptide Y is increased in an activated human HSC cell line.
Dai W; Liu Y; Zhang Y; Sun Y; Sun C; Zhang Y; Lv X
Sci Rep; 2019 Jul; 9(1):9500. PubMed ID: 31263154
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y release in the rat spinal cord measured with Y1 receptor internalization is increased after nerve injury.
Marvizon JC; Chen W; Fu W; Taylor BK
Neuropharmacology; 2019 Nov; 158():107732. PubMed ID: 31377198
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis.
Medeiros PJ; Jackson DN
Peptides; 2013 Oct; 48():106-13. PubMed ID: 23932937
[TBL] [Abstract][Full Text] [Related]
13. Involvement of neuropeptide Y and its Y1 and Y5 receptors in maintaining self-renewal and proliferation of human embryonic stem cells.
Son MY; Kim MJ; Yu K; Koo DB; Cho YS
J Cell Mol Med; 2011 Jan; 15(1):152-65. PubMed ID: 19874423
[TBL] [Abstract][Full Text] [Related]
14. Effect of incubation temperature on neuropeptide Y and neuropeptide Y receptors in turkey and chicken satellite cells.
Clark DL; McCormick JL; Velleman SG
Comp Biochem Physiol A Mol Integr Physiol; 2018 May; 219-220():58-66. PubMed ID: 29505887
[TBL] [Abstract][Full Text] [Related]
15. Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices.
King PJ; Widdowson PS; Doods HN; Williams G
J Neurochem; 1999 Aug; 73(2):641-6. PubMed ID: 10428060
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological inhibition of neuropeptide Y receptors Y1 and Y5 reduces hypoxic breast cancer migration, proliferation, and signaling.
Pascetta SA; Kirsh SM; Cameron M; Uniacke J
BMC Cancer; 2023 Jun; 23(1):494. PubMed ID: 37264315
[TBL] [Abstract][Full Text] [Related]
17. Chronic neuropeptide Y infusion into the lateral ventricle induces sustained feeding and obesity in mice lacking either Npy1r or Npy5r expression.
Raposinho PD; Pedrazzini T; White RB; Palmiter RD; Aubert ML
Endocrinology; 2004 Jan; 145(1):304-10. PubMed ID: 14525913
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y promotes beta-cell replication via extracellular signal-regulated kinase activation.
Cho YR; Kim CW
Biochem Biophys Res Commun; 2004 Feb; 314(3):773-80. PubMed ID: 14741702
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors.
Morris MJ; Gannan E; Stroud LM; Beck-Sickinger AG; O'Brien TJ
Eur J Neurosci; 2007 Feb; 25(4):1136-43. PubMed ID: 17331209
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line.
Sheriff S; Ali M; Yahya A; Haider KH; Balasubramaniam A; Amlal H
Mol Cancer Res; 2010 Apr; 8(4):604-14. PubMed ID: 20332211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
